Marston, Nicholas A.; Bergmark, Brian A.; Alexander, Veronica J.; Prohaska, Thomas A.; Kang, Yu Mi; Moura, Filipe A.; Zimerman, Andre; Waldman, Elaine; Weinland, Julia; Murphy, Sabina A.; Goodrich, Erica L.; Zhang, Shuanglu; Xia, Shuting; Li, Dan; Goldberg, Anne C.; Goudev, Assen; Badimon, Lina; Kiss, Robert Gabor; Vrablik, Michal; Gaudet, Daniel; Moulin, Philippe; Stroes, Erik S. G.; Banach, Maciej; Cohen, Hofit; Blom, Dirk; Charng, Min-Ji; Nordestgaard, Borge G.; Nicholls, Stephen J.; Tsimikas, Sotirios; Giugliano, Robert P.; Sabatine, Marc S.

Olezarsen in patients with hypertriglyceridemia at high cardiovascular risk: Rationale and design of the Essence-TIMI 73b trial

奥列扎森在心血管风险高的高甘油三酯血症患者中的研究：Essence-TIMI 73b试验的原理与设计

AMERICAN HEART JOURNAL

IF3.5

2025-05-100

OAAI

Glucagon-like peptide-1 receptor agonists lower risk of cardiovascular and non-cardiovascular mortality: A meta-analysis of eleven cardiovascular outcome trials

胰高血糖素样肽-1受体激动剂可降低心血管和非心血管死亡率风险：一项基于11项心血管结局试验的Meta分析

DIABETES OBESITY & METABOLISM

IF5.7

2025-05-080

PRE

Comparative Efficacy of Glucagon-Like Peptide 1 Receptor Agonists for Cardiovascular Outcomes in Asian Versus White Populations: Systematic Review and Meta-analysis of Randomized Trials of Populations With or Without Type 2 Diabetes and/or Overweight or Obesity

比较胰高血糖素样肽1受体激动剂在亚洲与白种人群中心血管结局的疗效：系统评价和随机试验的Meta分析（研究对象为有或无2型糖尿病和/或超重或肥胖的人群）

DIABETES CARE

IF16.6

2025-02-200

Is This the Real Life? Real-World Evidence of Empagliflozin in Health Care Resource Utilization and Cost

DIABETES CARE

IF16.6

2024-10-210

Genetic associations between pan-cancer and phenotype of COVID-19: A bidirectional Bayesian Weighted Mendelian randomization study

泛癌与COVID-19表型之间的遗传关联：一项双向贝叶斯加权孟德尔随机化研究

ANNALS OF ONCOLOGY

IF65.4

2024-09-010

PRE

Integrating network pharmacology with pharmacological research to elucidate the mechanism of modified Gegen Qinlian Decoction in treating porcine epidemic diarrhea

SCIENTIFIC REPORTS

IF3.9

2024-08-150

OAAI

Clinical Features and C-Peptide Levels Associated with Diabetic Ketoacidosis in Patients with Type 2 Diabetes on Dapagliflozin vs. Placebo-Insights from DECLARE-TIMI 58

DIABETES

IF7.5

2024-06-140

PRE

Fasting C-Peptide and Type 1 Diabetes Polygenic Score Predict Diabetic Ketoacidosis in People with Type 2 Diabetes in DECLARE-TIMI 58

DIABETES

IF7.5

2024-06-140

PRE

Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis

钠-葡萄糖Cotransporter-2抑制剂与主要不良心血管结局: smart-c协作荟萃分析

CIRCULATION

IF38.6

2024-06-049

OAAI

Patel, Siddharth M.; Kang, Yu Mi; Im, KyungAh; Neuen, Brendon L.; Anker, Stefan D.; Bhatt, Deepak L.; Butler, Javed; Cherney, David Z. I.; Claggett, Brian L.; Fletcher, Robert A.; Herrington, William G.; Inzucchi, Silvio E.; Jardine, Meg J.; Mahaffey, Kenneth W.; McGuire, Darren K.; McMurray, John J. V.; Neal, Bruce; Packer, Milton; Perkovic, Vlado; Solomon, Scott D.; Staplin, Natalie; Vaduganathan, Muthiah; Wanner, Christoph; Wheeler, David C.; Zannad, Faiez; Zhao, Yujie; Heerspink, Hiddo J. L.; Sabatine, Marc S.; Wiviott, Stephen D.

Impact of stress hyperglycemia ratio on mortality in patients with critical acute myocardial infarction: insight from american MIMIC-IV and the chinese CIN-II study

CARDIOVASCULAR DIABETOLOGY

IF10.6

2023-10-2124

OAAI

Association Between Systemic Immune Inflammation Level and Poor Prognosis Across Different Glucose Metabolism Status in Coronary Artery Disease Patients

inflammation research

IF4.1

2023-09-017